サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1402450

中南米の免疫診断市場の2030年までの予測-地域別分析-製品別、臨床適応症別、エンドユーザー別

South & Central America Immunodiagnostics Market Forecast to 2030 - Regional Analysis - by Product (Enzyme-Linked Immunosorbent Assays, Chemiluminescence Immunoassays, Radioimmunoassays, and Others), Clinical Indication, and End User

出版日
ページ情報
英文 199 Pages
納期
即納可能 即納可能とは
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.03円
中南米の免疫診断市場の2030年までの予測-地域別分析-製品別、臨床適応症別、エンドユーザー別
出版日: 2023年10月27日
発行: The Insight Partners
ページ情報: 英文 199 Pages
納期: 即納可能 即納可能とは
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

中南米の免疫診断市場は、2023年の9億5,572万米ドルから2030年には16億4,852万米ドルに成長すると予測されています。2023～2030年のCAGRは8.1%と推定されます。

感染症の増加が中南米の免疫診断市場を牽引

ウイルス、真菌、細菌、寄生虫、またはそれらの毒性産物などの感染性病原体によって引き起こされる増え続ける感染症の診断と管理は、免疫診断検査（補体固定、沈殿検査、凝集検査、ラインブロットアッセイ、ウェスタンブロットアッセイ、酵素免疫測定（EIA）、免疫蛍光検査など）の処方数を急増させています。

ヒト免疫不全ウイルス（HIV）は、世界的に公衆衛生上の大きな問題であり続けています。

さらに、結核（TB）、COVID-19、その他の院内感染（HAI）には免疫診断検査が必要です。

結核は死因の第13位であり、COVID-19に次いで第2位の感染症キラーです。2020年には150万人が結核で死亡し、世界で推定1,000万人（男性560万人、女性330万人、子供110万人）が罹患しています。

Worldometerによると、COVID-19の大流行により、世界中で数100万人の死亡が報告されました。このパンデミックは医療システムを疲弊させ、免疫診断学検査の必要性を高めました。

診断は、適切な治療法を決定する上で重要な役割を果たします。免疫診断は、免疫系に深刻な影響を与える疾患の診断に役立ちます。そのため、感染症の流行が免疫診断製品の需要急増につながっています。

中南米の免疫診断市場概要

World Population Ageing 2019」レポートによると、2019年のブラジルにおける65歳以上の高齢者数は1,952万6,000人で、2050年には5,202万6,000人に達すると予測されています。このような高齢者人口の増加は、高齢者がこれらのがんや他の慢性疾患に罹患しやすいことから、同国の肝臓がん、結腸がん、膵臓がんの有病率を高めると予想され、その結果、診断に対する需要が高まると考えられます。細菌やウイルスの大流行、ポイントオブケア診断に対する需要の増加、急速に進化する技術が分子診断の成長をさらに後押ししています。例えば、2020年11月、感染症に特化したポイントオブケア診断のリーディングカンパニーであるChem Bio Diagnostics, Inc.は、その子会社であるChem Bio Diagnostics Brazil LtdaがブラジルでDPP SARS-CoV-2抗原検査システムのAgencia Nacional de Vigilancia Sanitaria（ANVISA）の承認を取得したことを明らかにしました。ブラジルでは、NCDsも大きな健康問題を構成しており、特に心血管疾患（31.3％）、がん（16.3％）、糖尿病（5.2％）、慢性呼吸器疾患（5.8％）が死因の72％を占めています。このように、がん、糖尿病、その他の慢性疾患の増加により、免疫診断の需要が急増しています。

中南米の免疫診断市場の収益と2030年までの予測（金額）

中南米の免疫診断市場セグメンテーション

中南米の免疫診断市場は、製品、臨床適応症、エンドユーザー、国別に区分されます。

製品別では、中南米の免疫診断市場は酵素結合免疫吸着測定法（ELISA）、化学発光免疫測定法（CLIA）、ラジオイムノアッセイ（RIA）、その他に区分されます。2023年には、酵素結合免疫吸着測定法（ELISA）分野が南米免疫診断市場で最大のシェアを記録しました。化学発光免疫測定法（CLIA）セグメントはさらに、ビタミンDアッセイ市場、HIV検出市場、HIV ag/abコンボアッセイ市場、その他の検査に区分されます。

臨床適応症に基づき、中南米免疫診断市場は感染症、肝炎+HIV、内分泌、消化器、代謝、その他に区分されます。2023年には、感染症分野が中南米免疫診断市場で最大のシェアを記録しました。感染症分野はさらに、COVID-19、結核、ライム、感染管理、ジカ熱、トレポネーマ、トーチ、麻疹・おたふくかぜ、VZV、EBVに区分されます。内分泌分野はさらに、高血圧、成長、糖尿病、甲状腺、生殖内分泌に区分されます。

エンドユーザー別に見ると、中南米の免疫診断市場は病院、クリニック、診断研究所、学術・研究機関、その他に区分されます。2023年には、病院セグメントが中南米免疫診断市場で最大のシェアを記録しました。

国別では、中南米の免疫診断市場はブラジル、アルゼンチン、その他の南米に区分されます。2023年には、その他の南米セグメントが南米免疫診断市場で最大のシェアを記録しました。

Abbott Laboratories、bioMerieux SA、Danaher Corp、DiaSorin SpA、F. Hoffmann-La Roche Ltd、PerkinElmer Inc、Shenzhen Mindray Bio-Medical Electronics Co., Ltd.、Siemens Healthcare GmbH、Svar Life Science AB、and Thermo Fisher Scientific Inc.は、中南米の免疫診断市場に進出している大手企業です。

目次

第1章 イントロダクション

第2章 中南米の免疫診断市場-要点

第3章 調査手法

  • 調査範囲
  • 2次調査
  • 1次調査

第4章 中南米の免疫診断市場-市場情勢

  • イントロダクション
  • 中南米のPEST分析
  • 専門家の見解

第5章 中南米の免疫診断市場：主要市場力学

  • 市場の促進要因
    • 感染症罹患率の増加
    • ポイントオブケア免疫診断の利用拡大
  • 市場抑制要因
    • 不十分な償還シナリオ
  • 市場機会
    • 主要企業による研究開発投資と事業拡大への注目の高まり
  • 今後の動向
    • 免疫診断における技術の進歩
  • 影響分析

第6章 免疫診断市場：中南米分析

  • 中南米の免疫診断市場収益と予測分析

第7章 中南米の免疫診断市場分析-製品別

  • イントロダクション
  • 中南米の免疫診断市場：製品別、2022年・2030年（%）
  • 酵素結合免疫吸着測定法（ELISA）
  • 化学発光免疫測定法（CLIA）
  • ラジオイムノアッセイ（RIA）
  • その他

第8章 中南米の免疫診断市場の分析：臨床適応症

  • イントロダクション
  • 中南米の免疫診断市場：臨床適応症別シェア、2022年・2030年（%）
  • 感染症
    • 概要
      • COVID-19
      • 結核
      • ライム
      • 感染症管理
      • ジカ熱
      • トレポネーマ
      • トーチ
      • 麻疹と流行性耳下腺炎
      • VZV
      • EBV
  • 肝炎+HIV
  • 概要
  • 消化器
  • 概要
  • 代謝疾患
  • 概要
  • 内分泌学
    • 概要
    • 高血圧
    • 概要
    • 成長
    • 概要
    • 糖尿病
      • 糖尿病
    • 甲状腺
      • 内分泌学
    • 生殖内分泌学
      • 内分泌学
  • その他
    • その他

第9章 中南米の免疫診断市場の分析：エンドユーザー

  • イントロダクション
  • 中南米の免疫診断市場：エンドユーザー別シェア、2022年・2030年（%）
  • 病院
    • 病院
  • クリニック
  • 概要
  • 診断研究所
    • 研究機関
  • 学術・研究機関
  • 概要
  • その他
  • 概要

第10章 中南米の免疫診断市場：2030年までの収益と予測：国別分析

第11章 中南米の免疫診断市場：業界情勢

  • イントロダクション
  • 中南米の免疫診断市場における成長戦略
  • 無機的成長戦略
    • 無機的成長戦略
  • 有機的成長戦略

第12章 企業プロファイル

  • Abbott Laboratories
  • F. Hoffmann-La Roche Ltd
  • DiaSorin SpA
  • Danaher Corp
  • Thermo Fisher Scientific Inc
  • PerkinElmer Inc
  • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • bioMerieux SA
  • Svar Life Science AB
  • Siemens Healthcare GmbH

第13章 付録

図表

List Of Tables

  • Table 1. Brazil Immunodiagnostics Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 2. Brazil Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)- Revenue and Forecast to 2030 (US$ Million)
  • Table 3. Brazil Immunodiagnostics Market, by Clinical Indication - Revenue and Forecast to 2030 (US$ Million)
  • Table 4. Brazil Immunodiagnostics Market, by Infectious Diseases - Revenue and Forecast to 2030 (US$ Million)
  • Table 5. Brazil Immunodiagnostics Market, by Endocrinology - Revenue and Forecast to 2030 (US$ Million)
  • Table 6. Brazil Immunodiagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 7. Argentina Immunodiagnostics Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 8. Argentina Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)- Revenue and Forecast to 2030 (US$ Million)
  • Table 9. Argentina Immunodiagnostics Market, by Clinical Indication - Revenue and Forecast to 2030 (US$ Million)
  • Table 10. Argentina: Immunodiagnostics Market, by Infectious Diseases - Revenue and Forecast to 2030 (US$ Million)
  • Table 11. Argentina Immunodiagnostics Market, by Endocrinology - Revenue and Forecast to 2030 (US$ Million)
  • Table 12. Argentina Immunodiagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 13. Rest of South & Central America Immunodiagnostics Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 14. Rest of South & Central America Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)- Revenue and Forecast to 2030 (US$ Million)
  • Table 15. Rest of South & Central America Immunodiagnostics Market, by Clinical Indication - Revenue and Forecast to 2030 (US$ Million)
  • Table 16. Rest of South & Central America: Immunodiagnostics Market, by Infectious Diseases - Revenue and Forecast to 2030 (US$ Million)
  • Table 17. Rest of South & Central America Immunodiagnostics Market, by Endocrinology - Revenue and Forecast to 2030 (US$ Million)
  • Table 18. Rest of South & Central America Immunodiagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 19. Recent Inorganic Growth Strategies in the South & Central America immunodiagnostics market
  • Table 20. Recent Organic Growth Strategies in the South & Central America immunodiagnostics market
  • Table 21. Glossary of Terms, South & Central America Immunodiagnostics Market

List Of Figures

  • Figure 1. South & Central America Immunodiagnostics Market Segmentation
  • Figure 2. South & Central America Immunodiagnostics Market, by Country
  • Figure 3. South & Central America Immunodiagnostics Market Overview
  • Figure 4. Enzyme-Linked Immunosorbent Assays (ELISA) Segment Held Largest Share of Product Segment in South & Central America Immunodiagnostics Market
  • Figure 5. Argentina Expected to Show Remarkable Growth During Forecast Period
  • Figure 6. South & Central America: PEST Analysis
  • Figure 7. Experts' Opinion
  • Figure 8. South & Central America Immunodiagnostics Market: Impact Analysis of Drivers and Restraints
  • Figure 9. South & Central America Immunodiagnostics Market - Revenue Forecast and Analysis - 2021-2030
  • Figure 10. South & Central America Immunodiagnostics Market, by Product, 2022 & 2030 (%)
  • Figure 11. Enzyme-linked Immunosorbent Assays (ELISA): South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
  • Figure 12. Chemiluminescence Immunoassays (CLIA): South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
  • Figure 13. Vitamin D Assay: South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
  • Figure 14. HIV Detection: South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
  • Figure 15. HIV Ag/Ab Combo Assay: Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
  • Figure 16. Other Tests: South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
  • Figure 17. Radioimmunoassays (RIA): South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
  • Figure 18. Others: South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
  • Figure 19. South & Central America Immunodiagnostics Market Share by Clinical Indication - 2022 & 2030 (%)
  • Figure 20. Infectious Diseases: South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
  • Figure 21. COVID-19: Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
  • Figure 22. Tuberculosis: South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
  • Figure 23. Lyme: South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
  • Figure 24. Infection Management: South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
  • Figure 25. Zika: South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
  • Figure 26. Treponema: South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
  • Figure 27. TORCH: South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
  • Figure 28. Measles and Mumps: South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
  • Figure 29. VZV: South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
  • Figure 30. EBV: South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
  • Figure 31. Hepatitis+HIV: South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
  • Figure 32. Gastrointestinal: South & Central America Immunodiagnostics Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 33. Metabolics: South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
  • Figure 34. Endocrinology: Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
  • Figure 35. Hypertension: Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
  • Figure 36. Growth: South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
  • Figure 37. Diabetes: South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
  • Figure 38. Thyroid: South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
  • Figure 39. Reproductive Endocrinology: South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
  • Figure 40. Endocrinology: South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
  • Figure 41. South & Central America Immunodiagnostics Market Share by End User - 2022 & 2030 (%)
  • Figure 42. Hospitals: South & Central America Immunodiagnostics Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 43. Clinics: South & Central America Immunodiagnostics Market Revenue and Forecasts To 2030 (US$ Million)
  • Figure 44. Diagnostic Laboratories: South & Central America Immunodiagnostics Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 45. Academic and Research Institutes: South & Central America Immunodiagnostics Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 46. Others: South & Central America Immunodiagnostics Market Revenue and Forecasts to 2030 (US$ Million)
  • Figure 47. South & Central America Immunodiagnostics Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 48. South & Central America: Immunodiagnostics Market, by Country, 2022 & 2030 (%)
  • Figure 49. Brazil: Immunodiagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 50. Argentina: Immunodiagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 51. Rest of South & Central America: Immunodiagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 52. Growth Strategies in the South & Central America immunodiagnostics market
目次
Product Code: BMIRE00027836

The South & Central America immunodiagnostics market is expected to grow from US$ 955.72 million in 2023 to US$ 1,648.52 million by 2030. It is estimated to grow at a CAGR of 8.1% from 2023 to 2030.

Increasing Prevalence of Infectious Diseases Drive South & Central America Industrial Robotics Market

The diagnosis and management of several ever-growing infectious diseases caused by infectious agents such as viruses, fungi, bacteria, parasites, or their toxic products are surging number of prescriptions for immunodiagnostics tests, e.g., complement fixation, precipitation tests, agglutination tests, line blot assays, Western blot assays, enzyme immunoassays (EIA), and immunofluorescence tests.

Human immunodeficiency virus (HIV) continues to be a major public health issue worldwide.

Further, tuberculosis (TB), COVID-19, and other hospital-acquired infections (HAIs) require immunodiagnostics tests.

TB has been the 13th leading cause of death and the second-leading infectious killer after COVID-19. In 2020, 1.5 million people died from TB and affected an estimated 10 million people, comprising 5.6 million males, 3.3 million females, and 1.1 million children globally.

According to Worldometer, millions of deaths were reported worldwide due to the COVID-19 pandemic. It strained healthcare systems and increased the need for immunodiagnostics tests.

Diagnostics play a vital role in determining suitable medical treatments. Immunodiagnostics help diagnose diseases that severely impact the immune system. Hence, the rising prevalence of infectious diseases lead to the surging demand for immunodiagnostics products.

South & Central America Immunodiagnostics Market Overview

According to World Population Ageing 2019 report, the number of people aged above 65 years was 19.526 million in Brazil in 2019 and is expected to reach 52.026 million by 2050. This increase in the geriatric population is expected to raise the country's prevalence rate of liver, colon, and pancreatic cancer since older people are more prone to these cancers, as well as other chronic diseases, which would subsequently boost the demand for diagnostics. Large outbreaks of bacterial and viral pandemics, increasing demand for point-of-care diagnostics, and rapidly evolving technology are further propelling the growth of molecular diagnostics. For instance, in November 2020, Chembio Diagnostics, Inc., a leading point-of-care diagnostic company focused on infectious diseases, revealed that its subsidiary Chembio Diagnostics Brazil Ltda received Agencia Nacional de Vigilancia Sanitaria (ANVISA) approval for the DPP SARS-CoV-2 Antigen test system in Brazil. In Brazil, NCDs also constitute a health problem of a large magnitude and account for 72% of causes of death, especially cardiovascular diseases (31.3%), cancer (16.3%), diabetes (5.2%), and chronic respiratory disease (5.8%). Thus, the rising cases of cancer, diabetes, and other chronic diseases is surging the demand for immunodiagnostics.

South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

South & Central America Immunodiagnostics Market Segmentation

The South & Central America immunodiagnostics market is segmented into product, clinical indication, end user, and country.

Based on product, the South & Central America immunodiagnostics market is segmented into enzyme-linked immunosorbent assays (ELISA), chemiluminescence immunoassays (CLIA), radioimmunoassays (RIA), and others. In 2023, the enzyme-linked immunosorbent assays (ELISA) segment registered the largest share in the South & Central America immunodiagnostics market. The chemiluminescence immunoassays (CLIA) segment is further segmented into vitamin D assay market, HIV detection market, HIV ag/ab combo assay market, and other tests.

Based on clinical indication, the South & Central America immunodiagnostics market is segmented into infectious diseases, hepatitis+HIV, endocrinology, gastrointestinal, metabolics, and others. In 2023, the infectious diseases segment registered the largest share in the South & Central America immunodiagnostics market. The infectious diseases segment is further segmented into COVID-19, tuberculosis, lyme, infection management, zika, treponema, torch, measles and mumps, VZV, and EBV. The endocrinology segment is further segmented into hypertension, growth, diabetes, thyroid, and reproductive endocrinology.

Based on end user, the South & Central America immunodiagnostics market is segmented into hospitals, clinics, diagnostic laboratories, academic & research institutes, and others. In 2023, the hospitals segment registered the largest share in the South & Central America immunodiagnostics market.

Based on country, the South & Central America immunodiagnostics market is segmented into Brazil, Argentina, and the Rest of South & Central America. In 2023, the Rest of South & Central America segment registered the largest share in the South & Central America immunodiagnostics market.

Abbott Laboratories; bioMerieux SA; Danaher Corp; DiaSorin SpA; F. Hoffmann-La Roche Ltd; PerkinElmer Inc; Shenzhen Mindray Bio-Medical Electronics Co., Ltd.; Siemens Healthcare GmbH; Svar Life Science AB; and Thermo Fisher Scientific Inc are some of the leading companies operating in the South & Central America immunodiagnostics market.

Reasons to Buy:

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the South & Central America immunodiagnostics market.
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The key findings and recommendations highlight crucial progressive industry trends in the South & Central America immunodiagnostics market, thereby allowing players across the value chain to develop effective long-term strategies
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
  • Scrutinize in-depth South & Central America market trends and outlook coupled with the factors driving the immunodiagnostics market, as well as those hindering it
  • Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution

Table Of Contents

1. Introduction

  • 1.1 Scope of the Study
  • 1.2 The Insight Partners Research Report Guidance
  • 1.3 Market Segmentation
    • 1.3.1 South & Central America Immunodiagnostics Market - by Product
    • 1.3.2 South & Central America Immunodiagnostics Market - by Clinical Indication
    • 1.3.3 South & Central America Immunodiagnostics Market - by End User
    • 1.3.4 South & Central America Immunodiagnostics Market - by Country

2. South & Central America Immunodiagnostics Market - Key Takeaways

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. South & Central America Immunodiagnostics Market - Market Landscape

  • 4.1 Overview
  • 4.2 South & Central America PEST Analysis
  • 4.3 Expert's Opinion

5. South & Central America Immunodiagnostics Market - Key Market Dynamics

  • 5.1 Market Drivers
    • 5.1.1 Increasing Prevalence of Infectious Diseases
    • 5.1.2 Growing Use of Point-of-Care Immunodiagnostics
  • 5.2 Market Restraints
    • 5.2.1 Inadequate Reimbursement Scenario
  • 5.3 Market Opportunities
    • 5.3.1 Rising Focus on R&D Investment and Expansion by Key Players
  • 5.4 Future Trends
    • 5.4.1 Technological Advancements in Immunodiagnostics
  • 5.5 Impact Analysis

6. Immunodiagnostics Market - South & Central America Analysis

  • 6.1 South & Central America Immunodiagnostics Market Revenue Forecast and Analysis

7. South & Central America Immunodiagnostics Market Analysis - by Product

  • 7.1 Overview
  • 7.2 South & Central America Immunodiagnostics Market, By Product, 2022 & 2030 (%)
  • 7.3 Enzyme-linked Immunosorbent Assays (ELISA)
    • 7.3.1 Overview
    • 7.3.2 Enzyme-linked Immunosorbent Assays (ELISA): South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
  • 7.4 Chemiluminescence Immunoassays (CLIA)
    • 7.4.1 Overview
    • 7.4.2 Chemiluminescence Immunoassays (CLIA): South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
    • 7.4.3 Vitamin D Assay
      • 7.4.3.1 Overview
      • 7.4.3.2 Vitamin D Assay: South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
    • 7.4.4 HIV Detection
      • 7.4.4.1 Overview
      • 7.4.4.2 HIV Detection: South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
    • 7.4.5 HIV Ag/Ab Combo assay
      • 7.4.5.1 Overview
      • 7.4.5.2 HIV Ag/Ab Combo Assay: South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
    • 7.4.6 Other Tests
      • 7.4.6.1 Overview
      • 7.4.6.2 Other Tests: South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
  • 7.5 Radioimmunoassays (RIA)
    • 7.5.1 Overview
    • 7.5.2 Radioimmunoassays (RIA): South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
  • 7.6 Others
    • 7.6.1 Overview
    • 7.6.2 Others: South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

8. South & Central America Immunodiagnostics Market Analysis - Clinical Indication

  • 8.1 Overview
  • 8.2 South & Central America Immunodiagnostics Market Share by Clinical Indication - 2022 & 2030 (%)
  • 8.3 Infectious Diseases:
    • 8.3.1 Overview
    • 8.3.2 Infectious Diseases: South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
      • 8.3.2.1 COVID-19
        • 8.3.2.1.1 Overview
        • 8.3.2.1.2 COVID-19: South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
      • 8.3.2.2 Tuberculosis
        • 8.3.2.2.1 Overview
        • 8.3.2.2.2 Tuberculosis: South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
      • 8.3.2.3 Lyme
        • 8.3.2.3.1 Overview
        • 8.3.2.3.2 Lyme: South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
      • 8.3.2.4 Infection Management
        • 8.3.2.4.1 Overview
        • 8.3.2.4.2 Infection Management: South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
      • 8.3.2.5 Zika
        • 8.3.2.5.1 Overview
        • 8.3.2.5.2 Zika: South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
      • 8.3.2.6 Treponema
        • 8.3.2.6.1 Overview
        • 8.3.2.6.2 Treponema: South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
      • 8.3.2.7 TORCH
        • 8.3.2.7.1 Overview
        • 8.3.2.7.2 TORCH: South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
      • 8.3.2.8 Measles and Mumps
        • 8.3.2.8.1 Overview
        • 8.3.2.8.2 Measles and Mumps: South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
      • 8.3.2.9 VZV
        • 8.3.2.9.1 Overview
        • 8.3.2.9.2 VZV: South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
      • 8.3.2.10 EBV
        • 8.3.2.10.1 Overview
        • 8.3.2.10.2 EBV: South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
  • 8.4 Hepatitis+HIV:
    • 8.4.1 Overview
    • 8.4.2 Hepatitis+HIV: South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
  • 8.5 Gastrointestinal
    • 8.5.1 Overview
    • 8.5.2 Gastrointestinal: South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
  • 8.6 Metabolic Disorders
    • 8.6.1 Overview
    • 8.6.2 Metabolics: South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
  • 8.7 Endocrinology
    • 8.7.1 Overview
    • 8.7.2 Endocrinology: South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
    • 8.7.3 Hypertension
      • 8.7.3.1 Overview
      • 8.7.3.2 Hypertension: South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
    • 8.7.4 Growth
      • 8.7.4.1 Overview
      • 8.7.4.2 Growth: South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
    • 8.7.5 Diabetes
      • 8.7.5.1 Overview
      • 8.7.5.2 Diabetes: South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
    • 8.7.6 Thyroid
      • 8.7.6.1 Overview
      • 8.7.6.2 Thyroid: South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
    • 8.7.7 Reproductive Endocrinology
      • 8.7.7.1 Overview
      • 8.7.7.2 Reproductive Endocrinology: South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
  • 8.8 Others
    • 8.8.1 Overview
    • 8.8.2 Others: South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

9. South & Central America Immunodiagnostics Market Analysis - End User

  • 9.1 Overview
  • 9.2 South & Central America Immunodiagnostics Market Share by End User - 2022 & 2030 (%)
  • 9.3 Hospitals
    • 9.3.1 Overview
    • 9.3.2 Hospitals: South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
  • 9.4 Clinics
    • 9.4.1 Overview
    • 9.4.2 Clinics: South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
  • 9.5 Diagnostic Laboratories
    • 9.5.1 Overview
    • 9.5.2 Diagnostic Laboratories: South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
  • 9.6 Academic and Research Institutes
    • 9.6.1 Overview
    • 9.6.2 Academic and Research Institutes: South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)
  • 9.7 Others
    • 9.7.1 Overview
    • 9.7.2 Others: South & Central America Immunodiagnostics Market Revenue and Forecast to 2030 (US$ Million)

10. South & Central America Immunodiagnostics Market - Revenue and Forecast to 2030 - Country Analysis

  • 10.1 Overview
      • 10.1.1.1 Brazil: Immunodiagnostics Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.1.1 Overview
        • 10.1.1.1.2 Brazil: Immunodiagnostics Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.1.3 Brazil: Immunodiagnostics Market, by Product, 2020-2030 (US$ Million)
        • 10.1.1.1.3.1 Brazil: Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)- Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.1.4 Brazil: Immunodiagnostics Market, by Clinical Indication - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.1.4.1 Brazil: Immunodiagnostics Market, by Infectious Diseases - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.1.4.2 Brazil: Immunodiagnostics Market, by Endocrinology - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.1.5 Brazil: Immunodiagnostics Market, by End User, 2020-2030 (US$ Million)
      • 10.1.1.2 Argentina: Immunodiagnostics Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.2.1 Overview
        • 10.1.1.2.2 Argentina: Immunodiagnostics Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.2.3 Argentina: Immunodiagnostics Market, by Product, 2020-2030 (US$ Million)
        • 10.1.1.2.3.1 Argentina: Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)- Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.2.4 Argentina: Immunodiagnostics Market, by Clinical Indication - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.2.4.1 Argentina: Immunodiagnostics Market, by Infectious Diseases - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.2.4.2 Argentina: Immunodiagnostics Market, by Endocrinology - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.2.5 Argentina: Immunodiagnostics Market, by End User, 2020-2030 (US$ Million)
      • 10.1.1.3 Rest of South & Central America: Immunodiagnostics Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.3.1 Overview
        • 10.1.1.3.2 Rest of South & Central America: Immunodiagnostics Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.3.3 Rest of South & Central America: Immunodiagnostics Market, by Product, 2020-2030 (US$ Million)
        • 10.1.1.3.3.1 Rest of South & Central America: Immunodiagnostics Market, by Chemiluminescence Immunoassays (CLIA)- Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.3.4 Rest of South & Central America: Immunodiagnostics Market, by Clinical Indication - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.3.4.1 Rest of South & Central America: Immunodiagnostics Market, by Infectious Diseases - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.3.4.2 Rest of South & Central America: Immunodiagnostics Market, by Endocrinology - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.3.5 Rest of South & Central America: Immunodiagnostics Market, by End User, 2020-2030 (US$ Million)

11. South & Central America Immunodiagnostics Market -Industry Landscape

  • 11.1 Overview
  • 11.2 Growth Strategies in the South & Central America immunodiagnostics market
  • 11.3 Inorganic Growth Strategies
    • 11.3.1 Overview
  • 11.4 Organic Growth Strategies
    • 11.4.1 Overview

12. Company Profiles

  • 12.1 Abbott Laboratories
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Products and Services
    • 12.1.4 Financial Overview
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Developments
  • 12.2 F. Hoffmann-La Roche Ltd
    • 12.2.1 Key Facts
    • 12.2.2 Business Description
    • 12.2.3 Products and Services
    • 12.2.4 Financial Overview
    • 12.2.5 SWOT Analysis
    • 12.2.6 Key Developments
  • 12.3 DiaSorin SpA
    • 12.3.1 Key Facts
    • 12.3.2 Business Description
    • 12.3.3 Products and Services
    • 12.3.4 Financial Overview
    • 12.3.5 SWOT Analysis
    • 12.3.6 Key Developments
  • 12.4 Danaher Corp
    • 12.4.1 Key Facts
    • 12.4.2 Business Description
    • 12.4.3 Products and Services
    • 12.4.4 Financial Overview
    • 12.4.5 SWOT Analysis
    • 12.4.6 Key Developments
  • 12.5 Thermo Fisher Scientific Inc
    • 12.5.1 Key Facts
    • 12.5.2 Business Description
    • 12.5.3 Products and Services
    • 12.5.4 Financial Overview
    • 12.5.5 SWOT Analysis
    • 12.5.6 Key Developments
  • 12.6 PerkinElmer Inc
    • 12.6.1 Key Facts
    • 12.6.2 Business Description
    • 12.6.3 Products and Services
    • 12.6.4 Financial Overview
    • 12.6.5 SWOT Analysis
    • 12.6.6 Key Developments
  • 12.7 Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
    • 12.7.1 Key Facts
    • 12.7.2 Business Description
    • 12.7.3 Products and Services
    • 12.7.4 Financial Overview
    • 12.7.5 SWOT Analysis
    • 12.7.6 Key Developments
  • 12.8 bioMerieux SA
    • 12.8.1 Key Facts
    • 12.8.2 Business Description
    • 12.8.3 Products and Services
    • 12.8.4 Financial Overview
    • 12.8.5 SWOT Analysis
    • 12.8.6 Key Developments
  • 12.9 Svar Life Science AB
    • 12.9.1 Key Facts
    • 12.9.2 Business Description
    • 12.9.3 Products and Services
    • 12.9.4 Financial Overview
    • 12.9.5 SWOT Analysis
    • 12.9.6 Key Developments
  • 12.10 Siemens Healthcare GmbH
    • 12.10.1 Key Facts
    • 12.10.2 Business Description
    • 12.10.3 Products and Services
    • 12.10.4 Financial Overview
    • 12.10.5 SWOT Analysis
    • 12.10.6 Key Developments

13. Appendix

  • 13.1 About The Insight Partners
  • 13.2 Glossary of Terms